Compare Dr. Reddys with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs TTK HEALTHCARE - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB TTK HEALTHCARE DR. REDDYS LAB/
TTK HEALTHCARE
 
P/E (TTM) x 32.2 21.1 152.1% View Chart
P/BV x 4.5 1.4 318.7% View Chart
Dividend Yield % 0.5 1.1 48.0%  

Financials

 DR. REDDYS LAB   TTK HEALTHCARE
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
TTK HEALTHCARE
Mar-19
DR. REDDYS LAB/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs2,8751,215 236.6%   
Low Rs1,888610 309.5%   
Sales per share (Unadj.) Rs930.2444.4 209.3%  
Earnings per share (Unadj.) Rs117.417.2 680.8%  
Cash flow per share (Unadj.) Rs185.827.6 672.3%  
Dividends per share (Unadj.) Rs20.005.00 400.0%  
Dividend yield (eoy) %0.80.5 153.3%  
Book value per share (Unadj.) Rs844.4177.9 474.6%  
Shares outstanding (eoy) m166.0714.13 1,175.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.62.1 124.7%   
Avg P/E ratio x20.352.9 38.3%  
P/CF ratio (eoy) x12.833.0 38.8%  
Price / Book Value ratio x2.85.1 55.0%  
Dividend payout %17.029.0 58.8%   
Avg Mkt Cap Rs m395,49612,894 3,067.2%   
No. of employees `00022.02.3 950.1%   
Total wages/salary Rs m33,5621,307 2,567.9%   
Avg. sales/employee Rs Th7,032.82,715.7 259.0%   
Avg. wages/employee Rs Th1,527.9565.3 270.3%   
Avg. net profit/employee Rs Th887.7105.4 842.2%   
INCOME DATA
Net Sales Rs m154,4826,279 2,460.4%  
Other income Rs m3,37578 4,354.8%   
Total revenues Rs m157,8576,356 2,483.5%   
Gross profit Rs m31,782496 6,412.8%  
Depreciation Rs m11,348147 7,735.5%   
Interest Rs m88934 2,630.2%   
Profit before tax Rs m22,920393 5,838.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,858149 2,591.0%   
Profit after tax Rs m19,500244 8,001.6%  
Gross profit margin %20.67.9 260.6%  
Effective tax rate %16.837.9 44.4%   
Net profit margin %12.63.9 325.2%  
BALANCE SHEET DATA
Current assets Rs m111,1012,717 4,088.8%   
Current liabilities Rs m58,9731,571 3,754.3%   
Net working cap to sales %33.718.3 184.8%  
Current ratio x1.91.7 108.9%  
Inventory Days Days7932 246.8%  
Debtors Days Days9447 201.9%  
Net fixed assets Rs m101,245991 10,216.4%   
Share capital Rs m830141 587.4%   
"Free" reserves Rs m139,4062,373 5,874.7%   
Net worth Rs m140,2362,514 5,577.5%   
Long term debt Rs m22,0003 647,058.8%   
Total assets Rs m224,6564,158 5,402.9%  
Interest coverage x26.812.6 212.3%   
Debt to equity ratio x0.20 11,601.2%  
Sales to assets ratio x0.71.5 45.5%   
Return on assets %9.16.7 136.0%  
Return on equity %13.99.7 143.5%  
Return on capital %14.916.9 88.2%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m88,673225 39,375.2%   
Fx outflow Rs m19,10471 26,865.4%   
Net fx Rs m69,569154 45,148.3%   
CASH FLOW
From Operations Rs m28,704173 16,582.3%  
From Investments Rs m-7,72797 -8,007.3%  
From Financial Activity Rs m-21,326-307 6,939.8%  
Net Cashflow Rs m-314-38 832.9%  

Share Holding

Indian Promoters % 25.5 65.4 39.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.4 3.7 145.9%  
FIIs % 35.3 5.2 678.8%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 25.8 59.3%  
Shareholders   75,885 12,723 596.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   IPCA LABS  SANOFI INDIA  ALKEM LABORATORIES  ORCHID PHARMA LTD  NOVARTIS  

Compare DR. REDDYS LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 187 Points Higher(Closing)

Indian share markets end on a positive note with the Sensex up by 187 points, while the Nifty closed up by 36 points.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jul 7, 2020 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS